Prodea, A.; Milan, A.; Mioc, M.; Mioc, A.; Oprean, C.; Racoviceanu, R.; Negrea-Ghiulai, R.; Mardale, G.; Avram, Ș.; Balan-Porcărașu, M.;
et al. Novel Betulin-1,2,4-Triazole Derivatives Promote In Vitro Dose-Dependent Anticancer Cytotoxicity. Processes 2024, 12, 24.
https://doi.org/10.3390/pr12010024
AMA Style
Prodea A, Milan A, Mioc M, Mioc A, Oprean C, Racoviceanu R, Negrea-Ghiulai R, Mardale G, Avram Ș, Balan-Porcărașu M,
et al. Novel Betulin-1,2,4-Triazole Derivatives Promote In Vitro Dose-Dependent Anticancer Cytotoxicity. Processes. 2024; 12(1):24.
https://doi.org/10.3390/pr12010024
Chicago/Turabian Style
Prodea, Alexandra, Andreea Milan, Marius Mioc, Alexandra Mioc, Camelia Oprean, Roxana Racoviceanu, Roxana Negrea-Ghiulai, Gabriel Mardale, Ștefana Avram, Mihaela Balan-Porcărașu,
and et al. 2024. "Novel Betulin-1,2,4-Triazole Derivatives Promote In Vitro Dose-Dependent Anticancer Cytotoxicity" Processes 12, no. 1: 24.
https://doi.org/10.3390/pr12010024
APA Style
Prodea, A., Milan, A., Mioc, M., Mioc, A., Oprean, C., Racoviceanu, R., Negrea-Ghiulai, R., Mardale, G., Avram, Ș., Balan-Porcărașu, M., Rotunjanu, S., Trandafirescu, C., Şoica, I., & Șoica, C.
(2024). Novel Betulin-1,2,4-Triazole Derivatives Promote In Vitro Dose-Dependent Anticancer Cytotoxicity. Processes, 12(1), 24.
https://doi.org/10.3390/pr12010024